Type III effector-mediated processes in Salmonella infection

Future Microbiology

Volumn 7, Issue 6, 2012, Pages 685-703

  Van Der Heijden, Joris ^a,b   Finlay, B Brett ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

effector; infection; post translational modification; regulation; Salmonella; systems biology; type III secretion

Indexed keywords

AVRA PROTEIN; BACTERIAL PROTEIN; GOGB PROTEIN; PIBB PROTEIN; SALMONELLA INDUCED FILAMENT A; SALMONELLA INDUCED FILAMENT B; SIPA PROTEIN; SIPB PROTEIN; SIPC PROTEIN; SIPD PROTEIN; SLRP PROTEIN; SOPA PROTEIN; SOPB PROTEIN; SOPD PROTEIN; SOPD2 PROTEIN; SOPE PROTEIN; SPIC PROTEIN; SPVB PROTEIN; SPVC PROTEIN; SSEF PROTEIN; SSEG PROTEIN; SSEI PROTEIN; SSEJ PROTEIN; SSEK1 PROTEIN; SSEK2 PROTEIN; SSEL PROTEIN; SSPH1 PROTEIN; SSPH2 PROTEIN; STEA PROTEIN; STEC PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; BACTERIAL VIRULENCE; BIOGENESIS; CELL INVASION; CELL MATURATION; CELL VACUOLE; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; GENE INDUCTION; GENETIC REGULATION; INFLAMMATION; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS SYRINGAE; REVIEW; SALMONELLA CONTAINING VACUOLE; SALMONELLA PATHOGENICITY ISLAND 1; SALMONELLOSIS; SYSTEMS BIOLOGY; TYPE III SECRETION SYSTEM;

ANIMALS; BACTERIAL SECRETION SYSTEMS; HUMANS; MODELS, BIOLOGICAL; SALMONELLA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; VIRULENCE FACTORS;

EID: 84862560418     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.49     Document Type: Review

References (118)

1. Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature 449(7164), 827-834 (2007). (Pubitemid 47598623)
2. Bhavsar AP, Auweter SD, Finlay BB. Proteomics as a probe of microbial pathogenesis and its molecular boundaries. Future Microbiol. 5(2), 253-265 (2010).
3. Cornelis GR, Van Gijsegem F. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54, 735-774 (2000).
4. Finlay BB. The art of bacterial warfare. Sci. Am. 302(2), 56-63 (2010).
5. Valdez Y, Ferreira RBR, Finlay BB. Molecular mechanisms of Salmonella virulence and host resistance. Curr. Top. Microbiol. 337, 93-127 (2009).
6. Ohl ME, Miller SI. Salmonella: a model for bacterial pathogenesis. Annu. Rev. Med. 52, 259-274 (2001). (Pubitemid 32195324)
7. McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V. Salmonella takes control: effector-driven manipulation of the host. Curr. Opin. Microbiol. 12(1), 117-124 (2009).
8. Ekperigin HE, Nagaraja KV. Microbial food borne pathogens. Salmonella. Vet. Clin. North Am. Food Anim. Pract. 14(1), 17-29 (1998).
9. Sansonetti PJ. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4(12), 953-964 (2004). (Pubitemid 39620070)
10. Lee CA, Silva M, Siber AM, Kelly AJ, Galyov E, Mccormick BA. A secreted Salmonella protein induces a proinflammatory response in epithelial cells, which promotes neutrophil migration. Proc. Natl Acad. Sci. USA 97(22), 12283-12288 (2000).
11. Wall DM, Nadeau WJ, Pazos MA, Shi HN, Galyov EE, McCormick BA. Identification of the Salmonella enterica serotype Typhimurium SipA domain responsible for inducing neutrophil recruitment across the intestinal epithelium. Cell Microbiol. 9(9), 2299-2313 (2007). (Pubitemid 47250300)
12. Drecktrah D, Knodler LA, Ireland R, Steele-Mortimer O. The mechanism of Salmonella entry determines the vacuolar environment and intracellular gene expression. Traffic 7(1), 39-51 (2006).
13. Bakowski MA, Braun V, Brumell JH: Salmonella-containing vacuoles: directing traffic and nesting to grow. Traffic 9(12) 2022-2031 (2008).
14. Steele-Mortimer O. The Salmonella-containing vacuole-moving with the times. Curr. Opin. Microbiol. 11(1), 38-45 (2008).
15. Brumell JH, Goosney DL, Finlay BB. SifA, a type III secreted effector of Salmonella Typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. Traffic 3(6), 407-415 (2002). (Pubitemid 34746408)
16. Brumell JH, Tang P, Mills SD, Finlay BB. Characterization of Salmonella-induced filaments (Sifs) reveals a delayed interaction between Salmonella-containing vacuoles and late endocytic compartments. Traffic 2(9), 643-653 (2001). (Pubitemid 32825703)
17. Catron DM, Lange Y, Borensztajn J, Sylvester MD, Jones BD, Haldar K. Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect. Immun. 72(2), 1036-1042 (2004) (Pubitemid 38166686)
18. Knodler LA, Steele-Mortimer O. Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic 4(9), 587-599 (2003). (Pubitemid 37062682)
19. Malik Kale P, Jolly CE, Lathrop S, Winfree S, Luterbach C, Steele-Mortimer O. Salmonella-at home in the host cell. Front. Microbiol. 2, 125 (2011).
20. Marcus SL, Brumell JH, Pfeifer CG, Finlay BB. Salmonella pathogenicity islands: big virulence in small packages. Microbes Infect. 2(2), 145-156 (2000). (Pubitemid 30154704)
21. Brown NF, Finlay BB. Potential origins and horizontal transfer of type III secretion systems and effectors. Mob. Genet. Elements 1(2), 118-121 (2011).
22. Cirillo DM, Valdivia RH, Monack DM, Falkow S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30(1), 175-188 (1998). (Pubitemid 28446629)
23. Waterman SR, Holden DW. Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol. 5(8), 501-511 (2003). (Pubitemid 36939590)
24. Brown NF, Vallance BA, Coombes BK, Valdez Y, Coburn BA, Finlay BB. Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine. PLoS Pathog. 1(3), e32 (2005).
25. Agbor TA, McCormick BA. Salmonella effectors: important players modulating host cell function during infection. Cell Microbiol. 13(12), 1858-1869 (2011).
26. Coburn B, Li YL, Owen D, Vallance BA, Finlay BB. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect. Immun. 73(6), 3219-3227 (2005). (Pubitemid 40745861)
27. Brawn LC, Hayward RD, Koronakis V. Salmonella SPI1 effector SipA persists after entry and cooperates with a SPI2 effector to regulate phagosome maturation and intracellular replication. Cell Host Microbe 1(1), 63-75 (2007). (Pubitemid 46506010)
28. Buckner MMC, Croxen MA, Arena ET, Finlay BB. A comprehensive study of the contribution of Salmonella enterica serovar Typhimurium SPI2 effectors to bacterial colonization, survival and replication in typhoid fever, macrophage and epithelial cell infection models. Virulence 2(3), 208-216 (2011).
29. Schlumberger MC, Hardt WD. Salmonella type III secretion effectors: pulling the host cell's strings. Curr. Opin. Microbiol. 9(1), 46-54 (2006). (Pubitemid 43184337)
30. Brown NF, Szeto J, Jiang XJ, Coombes BK, Finlay BB, Brumell JH. Mutational analysis of Salmonella translocated effector members SifA and SopD2 reveals domains implicated in translocation, subcellular localization and function. Microbiology 152, 2323-2343 (2006). (Pubitemid 44219641)
31. Auweter SD, Bhavsar AP, De Hoog CL et al. Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners. J. Biol. Chem. 286(27), 24023-24035 (2011).
32. Hayward RD, Koronakis V. Direct modulation of the host cell cytoskeleton by Salmonella actin-binding proteins. Trends Cell Biol. 12(1), 15-20 (2002). (Pubitemid 34164152)
33. Shan L, He P, Sheen J. Intercepting host MAPK signaling cascades by bacterial type III effectors. Cell Host Microbe 1(3), 167-174 (2007). (Pubitemid 46706366)
34. Coombes BK, Coburn BA, Potter AA et al. Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect. Immun. 73(11), 7161-7169 (2005). (Pubitemid 41587613)
35. Bajaj V, Lucas RL, Hwang C, Lee CA. Co-ordinate regulation of Salmonella Typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol. 22(4), 703-714 (1996). (Pubitemid 26385239)
36. Eichelberg K, Galan JE. Differential regulation of Salmonella Typhimurium type III secreted proteins by pathogenicity island 1 (SPI-1)-encoded transcriptional activators InvF and HilA. Infect. Immun. 67(8), 4099-4105 (1999). (Pubitemid 29357033)
37. Lara-Tejero M, Galan JE. Salmonella enterica serovar Typhimurium pathogenicity island 1-encoded type iii secretion system translocases mediate intimate attachment to nonphagocytic cells. Infect. Immun. 77(7), 2635-2642 (2009).
38. Hayward RD, Cain RJ, McGhie EJ, Phillips N, Garner MJ, Koronakis V. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol. Microbiol. 56(3), 590-603 (2005). (Pubitemid 40562355)
39. Nichols CD, Casanova JE. Salmonella-directed recruitment of new membrane to invasion foci via the host exocyst complex. Curr. Biol. 20(14), 1316-1320 (2010).
40. Haraga A, Ohlson MB, Miller SI. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 6(1), 53-66 (2008). (Pubitemid 350286220)
41. Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M, Hardt WD. Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72(2), 795-809 (2004). (Pubitemid 38166658)
42. Boyle EC, Brown NF, Finlay BB. Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell Microbiol. 8(12), 1946-1957 (2006). (Pubitemid 44680874)
43. Raffatellu M, Wilson RP, Chessa D et al. SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype Typhimurium invasion of epithelial cells. Infect. Immun. 73(1), 146-154 (2005). (Pubitemid 40041104)
44. Patel JC, Galan JE. Manipulation of the host actin cytoskeleton by Salmonella-all in the name of entry. Curr. Opin. Microbiol. 8(1), 10-15 (2005). (Pubitemid 40203220)
45. Friebel A, Ilchmann H, Aelpfelbacher M, Ehrbar K, Machleidt W, Hardt WD. SopE and SopE2 from Salmonella Typhimurium activate different sets of RhoGTPases of the host cell. J. Biol. Chem. 276(36), 34035-34040 (2001).
46. Patel JC, Galan JE. Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J. Cell Biol. 175(3), 453-463 (2006).
47. Zhou D, Chen LM, Hernandez L, Shears SB, Galan JE. A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol. Microbiol. 39(2), 248-259 (2001). (Pubitemid 32113499)
48. McGhie EJ, Hayward RD, Koronakis V. Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin. EMBO J. 20(9), 2131-2139 (2001). (Pubitemid 32410583)
49. Zhou DG, Mooseker MS, Galan JE. An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc. Natl Acad. Sci. USA 96(18), 10176-10181 (1999). (Pubitemid 29422532)
50. Myeni SK, Zhou D. The C terminus of SipC binds and bundles F-actin to promote Salmonella invasion. J. Biol. Chem. 285(18), 13357-13363 (2010).
51. Humphreys D, Hume PJ, Koronakis V. The Salmonella effector SptP dephosphorylates host AAA+ ATPase VCP to promote development of its intracellular replicative niche. Cell Host Microbe 5(3), 225-233 (2009).
52. Stender S, Friebel A, Linder S, Rohde M, Mirold S, Hardt WD. Identification of SopE2 from Salmonella Typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol. Microbiol. 36(6), 1206-1221 (2000). (Pubitemid 30449959)
53. Rogers LD, Kristensen AR, Boyle EC et al. Identification of cognate host targets and specific ubiquitylation sites on the Salmonella SPI-1 effector SopB/SigD. J. Proteomics 71(1), 97-108 (2008). (Pubitemid 351697865)
54. Rogers LD, Brown NF, Fang Y, Pelech S, Foster LJ. Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events. Sci. Signal. 4(191), rs9 (2011).
55. Srikanth CV, Wall DM, Maldonado-Contreras A et al. Salmonella pathogenesis and processing of secreted effectors by caspase-3. Science 330(6002), 390-393 (2010).
56. Zhang Y, Higashide WM, McCormick BA, Chen J, Zhou DG. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase. Mol. Microbiol. 62(3), 786-793 (2006). (Pubitemid 44571602)
57. Raupach B, Peuschel SK, Monack DM, Zychlinsky A. Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect. Immun. 74(8), 4922-4926 (2006). (Pubitemid 44157282)
58. Guiney DG. The role of host cell death in Salmonella infections. Curr. Top. Microbiol. Immunol. 289, 131-150 (2005). (Pubitemid 40283461)
59. Haraga A, Miller SI. A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol. 8(5), 837-846 (2006).
60. Wu H, Jones RM, Neish AS. The Salmonella effector AvrA mediates bacterial intracellular survival during infection in vivo. Cell Microbiol. 14(1), 28-39 (2012).
61. Lin SL, Le TX, Cowen DS. SptP, a Salmonella Typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation. Cell Microbiol. 5(4), 267-275 (2003). (Pubitemid 36511573)
62. Knodler LA, Finlay BB, Steele-Mortimer O. The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J. Biol. Chem. 280(10), 9058-9064 (2005). (Pubitemid 40409599)
63. Kuijl C, Savage NDL, Marsman M et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450(7170), 725-730 (2007). (Pubitemid 350207691)
64. Haneda T, Ishii Y, Shimizu H et al. Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cell Microbiol. 14(4), 485-499 (2011).
65. Le Negrate G, Faustin B, Welsh K et al. Salmonella secreted factor L deubiquitinase of Salmonella Typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J. Immunol. 180(7), 5045-5056 (2008).
66. Bernal-Bayard J, Ramos-Morales F. Salmonella Type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin. J. Biol. Chem. 284(40), 27587-27595 (2009).
67. Bernal-Bayard J, Cardenal-Munoz E, Ramos-Morales F. The Salmonella type III secretion effector, Salmonella leucine-rich repeat protein (SlrP), targets the human chaperone ERdj3. J. Biol. Chem. 285(21), 16360-16368 (2010).
68. Guiney DG, Fierer J. The role of the spv genes in Salmonella pathogenesis. Front. Microbiol. 2, 129 (2011).
69. Dai S, Zhang Y, Weimbs T, Yaffe MB, Zhou D. Bacteria-generated PtdIns(3)P recruits VAMP8 to facilitate phagocytosis. Traffic 8(10), 1365-1374 (2007). (Pubitemid 47394241)
70. Hernandez LD, Hueffer K, Wenk MR, Galan JE. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304(5678), 1805-1807 (2004). (Pubitemid 38787897)
71. Cain RJ, Hayward RD, Koronakis V. Deciphering interplay between Salmonella invasion effectors. PLoS Pathog. 4(4), e1000037 (2008).
72. Bakowski MA, Cirulis JT, Brown NF, Finlay BB, Brumell JH. SopD acts cooperatively with SopB during Salmonella enterica serovar Typhimurium invasion. Cell Microbiol. 9(12), 2839-2855 (2007). (Pubitemid 350066569)
73. Ibarra JA, Steele-Mortimer O. Salmonella-the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol. 11(11), 1579-1586 (2009).
74. Arpaia N, Godec J, Lau L et al. TLR signaling is required for Salmonella Typhimurium virulence. Cell 144(5), 675-688 (2011).
75. Walthers D, Carroll RK, Navarre WWWW, Libby SJ, Fang FC, Kenney LJ. The response regulator SsrB activates expression of diverse Salmonella pathogenicity island 2 promoters and counters silencing by the nucleoid-associated protein H-NS. Mol. Microbiol. 65(2), 477-493 (2007). (Pubitemid 47052729)
76. Nikolaus T, Deiwick J, Rappl C et al. SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J. Bacteriol. 183(20), 6036-6045 (2001). (Pubitemid 32917423)
77. Abrahams GL, Muller P, Hensel M. Functional dissection of SseF, a type III effector protein involved in positioning the Salmonella-containing vacuole. Traffic 7(8), 950-965 (2006).
78. Shotland Y, Kramer H, Groisman EA. The Salmonella SpiC protein targets the mammalian Hook3 protein function to alter cellular trafficking. Mol. Microbiol. 49(6), 1565-1576 (2003). (Pubitemid 37153516)
79. Dumont A, Boucrot E, Drevensek S et al. SKIP, the host target of the Salmonella virulence factor SifA, promotes kinesin-1-dependent vacuolar membrane exchanges. Traffic 11(7), 899-911 (2010).
80. Jackson LK, Nawabi P, Hentea C, Roark EA, Haldar K. The Salmonella virulence protein SifA is a G protein antagonist. Proc. Natl Acad. Sci. USA 105(37), 14141-14146 (2008).
81. Ohlson MB, Fluhr K, Birmingham CL, Brumell JH, Miller SI. SseJ deacylase activity by Salmonella enterica serovar Typhimurium promotes virulence in mice. Infect. Immun. 73(10), 6249-6259 (2005). (Pubitemid 41368786)
82. Christen M, Coye LH, Hontz JS et al. Activation of a bacterial virulence protein by the GTPase RhoA. Sci. Signal. 2(95), ra71 (2009).
83. Ruiz-Albert J, Yu XJ, Beuzon CR, Blakey AN, Galyov EE, Holden DW. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella Typhimurium vacuolar membrane. Mol. Microbiol. 44(3), 645-661 (2002). (Pubitemid 34526577)
84. Schroeder N, Henry T, De Chastellier C et al. The virulence protein SopD2 regulates membrane dynamics of Salmonella-containing vacuoles. PLoS Pathog. 6(7), e1001002 (2010).
85. Mota LJ, Ramsden AE, Liu M, Castle JD, Holden DW. SCAMP3 is a component of the Salmonella-induced tubular network and reveals an interaction between bacterial effectors and post-Golgi trafficking. Cell Microbiol. 11(8), 1236-1253 (2009).
86. Poh J, Odendall C, Spanos A et al. SteC is a Salmonella kinase required for SPI-2-dependent F-actin remodelling. Cell Microbiol. 10(1), 20-30 (2008). (Pubitemid 350239053)
87. Srikanth CV, Mercado-Lubo R, Hallstrom K, Mccormick BA. Salmonella effector proteins and host-cell responses. Cell. Mol. Life Sci. 68(22), 3687-3697 (2011).
88. Miao EA, Brittnacher M, Haraga A, Jeng RL, Welch MD, Miller SI. Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton. Mol. Microbiol. 48(2), 401-415 (2003). (Pubitemid 36819077)
89. Nawabi P, Catron DM, Haldar K. Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection. Mol. Microbiol. 68(1), 173-185 (2008). (Pubitemid 351363784)
90. Arena ET, Auweter SD, Antunes LC et al. The deubiquitinase activity of the Salmonella pathogenicity island 2 effector, SseL, prevents accumulation of cellular lipid droplets. Infect. Immun. 79(11), 4392-4400 (2011).
91. Trombert AN, Berrocal L, Fuentes JA, Mora GC. S. Typhimurium sseJ gene decreases the S. Typhi cytotoxicity toward cultured epithelial cells. BMC Microbiol. 10, 312 (2010).
92. Auweter SD, Yu HB, Arena ET, Guttman JA, Finlay BB. Oxysterol-binding protein (OSBP) enhances replication of intracellular Salmonella and binds the Salmonella SPI-2 effector SseL via its N-terminus. Microbes Infect. 14(2), 148-154 (2011).
93. Liu JZ, Jellbauer S, Poe AJ et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe 11(3), 227-239 (2012).
94. Osman D, Cavet JS. Metal sensing in Salmonella: implications for pathogenesis. Adv. Microb. Physiol. 58, 175-232 (2011).
95. Dean P. Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol. Rev. 35(6), 1100-1125 (2011).
96. Yarbrough ML, Li Y, Kinch LN, Grishin NV, Ball HL, Orth K. AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 323(5911), 269-272 (2009).
97. Niemann GS, Brown RN, Gustin JK et al. Discovery of novel secreted virulence factors from Salmonella enterica serovar Typhimurium by proteomic analysis of culture supernatants. Infect. Immun. 79(1), 33-43 (2011).
98. Yu XJ, McGourty K, Liu M, Unsworth KE, Holden DW. pH sensing by intracellular Salmonella induces effector translocation. Science 328(5981), 1040-1043 (2010).
99. Lara-Tejero M, Kato J, Wagner S, Liu XY, Galan JE. A sorting platform determines the order of protein secretion in bacterial type III systems. Science 331(6021), 1188-1191 (2011).
100. Winnen B, Schlumberger MC, Sturm A et al. Hierarchical effector protein transport by the Salmonella Typhimurium SPI-1 type III secretion system. PLoS One 3(5), e2178 (2008).
101. Kubori T, Galan JE. Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115(3), 333-342 (2003). (Pubitemid 37487706)
102. Knodler LA, Winfree S, Drecktrah D, Ireland R, Steele-Mortimer O. Ubiquitination of the bacterial inositol phosphatase, SopB, regulates its biological activity at the plasma membrane. Cell Microbiol. 11(11), 1652-1670 (2009).
103. Hicks SW, Charron G, Hang HC, Galan JE. Subcellular targeting of Salmonella virulence proteins by host-mediated S-palmitoylation. Cell Host Microbe 10(1), 9-20 (2011).
104. Van Engelenburg SB, Palmer AE. Imaging type-III secretion reveals dynamics and spatial segregation of Salmonella effectors. Nat. Methods 7(4), 325-330 (2010).
105. Deiwick J, Salcedo SP, Boucrot E et al. The translocated Salmonella effector proteins SseF and SseG interact and are required to establish an intracellular replication niche. Infect. Immun. 74(12), 6965-6972 (2006). (Pubitemid 44913172)
106. Jayaswal S, Kamal MA, Dua R et al. Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA Screen. PLoS Pathog. 6(4), e1000839 (2010).
107. Boucrot E, Beuzon CR, Holden DW, Gorvel JP, Meresse S. Salmonella Typhimurium SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its biological function. J. Biol. Chem. 278(16), 14196-14202 (2003). (Pubitemid 36799967)
108. Reinicke AT, Hutchinson JL, Magee AI, Mastroeni P, Trowsdale J, Kelly AP. A Salmonella Typhimurium effector protein SifA is modified by host cell prenylation and S-acylation machinery. J. Biol. Chem. 280(15), 14620-14627 (2005). (Pubitemid 40562807)
109. Dowen RH, Engel JL, Shao F, Ecker JR, Dixon JE. A family of bacterial cysteine protease type III effectors utilizes acylation-dependent and-independent strategies to localize to plasma membranes. J. Biol. Chem. 284(23), 15867-15879 (2009).
110. Jers C, Pedersen MM, Paspaliari DK et al. Bacillus subtilis BY-kinase PtkA controls enzyme activity and localization of its protein substrates. Mol. Microbiol. 77(2), 287-299 (2010).
111. Du FY, Galan JE. Selective inhibition of type III Secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog. 5(9), e1000595 (2009).
112. Anderson JC, Pascuzzi PE, Xiao FM, Sessa G, Martin GB. Host-mediated phosphorylation of type III effector AvrPto promotes Pseudomonas virulence and avirulence in tomato. Plant Cell 18(2), 502-514 (2006). (Pubitemid 43951309)
113. Zhang Y, Higashide W, Dai SP, Sherman DM, Zhou DG. Recognition and ubiquitination of Salmonella type III effector SopA by a ubiquitin E3 ligase, HsRMA1. J. Biol. Chem. 280(46), 38682-38688 (2005). (Pubitemid 43853771)
114. Vogels MW, Van Balkom BW, Heck AJ et al. Quantitative proteomic identification of host factors involved in the Salmonella Typhimurium infection cycle. Proteomics 11(23), 4477-4491 (2011).
115. Antunes LC, Arena ET, Menendez A et al. Impact of Salmonella infection on host hormone metabolism revealed by metabolomics. Infect. Immun. 79(4), 1759-1769 (2011).
116. McDermott JE, Corrigan A, Peterson E et al. Computational prediction of type III and IV secreted effectors in Gram-negative bacteria. Infect. Immun. 79(1), 23-32 (2011).
117. Geddes K, Cruz F, Heffron F. Analysis of cells targeted by Salmonella type III secretion in vivo. PLoS Pathog. 3(12), e196 (2007).
118. Muller AJ, Kaiser P, Dittmar KE et al. Salmonella gut invasion involves TTSS-2-dependent epithelial traversal, basolateral exit, and uptake by epithelium-sampling lamina propria phagocytes. Cell Host Microbe 11(1), 19-32 (2012).